NCOG Still Alive, But Not Without Fight On NCAB In Test Of Regional Cooperative Group Concept
In Brief: NCI Grants Get More Money, Pay Line Boosted To 193
For R01s, 195 or P01s Center Funds Up By $600,000
DCAB Board Okays One Contract Concept, Sends Another Back to Drawing Board
NCI Continues Making Improvements In Contract Management
Shubik Warns NCA Members They May Be Prober’s Next Target
FDA Committee Agenda Includes M-AMSA, THC, Estramustine, Platinum
Trending Stories
- DOD cancer research programs face 57% funding cut in year-long continuing resolution
Pancreatic, lung, kidney cancer research programs eliminated - Karen Knudsen tells us why she took the CEO job at the Parker Institute for Cancer Immunotherapy
- Brian Druker, developer of Gleevec, eyes a new feat: Setting the Boston Marathon fundraising record
Current record: $507,000. Proceeds to go to LLS as NIH funding is slashed - Amid HHS upheaval, Bhattacharya takes the helm at NIH, Makary at FDA
Meanwhile, NASEM sounds “SOS” for health infrastructure - What Trump’s pick of RFK Jr. means for cancer: Epidemics, HPV, stunted research
Former FDA Commissioner Scott Gottlieb expresses “deep concerns” - In The Headlines: Private funding can’t replace federal funding—but it can help